Daré Bioscience CEO presents at Virtual Investor “Why Now” on-demand series

DARE•2026-08-27

Virtual Investor on-demand series appearance

Daré Bioscience participated in the Virtual Investor “Why Now” on-demand series.

CEO Sabrina Martucci Johnson outlined the company’s investment thesis, citing a direct product launch, pipeline breadth, and collaboration-led development.

The event webcast was made available for on-demand viewing.

Daré Bioscience CEO presents at Virtual Investor “Why Now” on-demand series

Virtual Investor on-demand series appearance

Related News

Kuber Resources names CEO Raymond Fu as CFO after Li Jiyong resignation

CrowdStrike Holdings, Inc. <CRWD.O>: UBS Raises Target Price to $250 From $235

Amex Halt CRWC.A Add Info Lst 24.252400

argenx completes acquisition of Forte Biosciences for $77 per share

LIVE MARKETS-Nvidia sparks Nasdaq, but Jackson Hole still awaits